Tokyo, Japan – November 6, 2024 – Sentinel Environmental and CarbGeM Inc. today announced a research collaboration agreement to create a novel platform to discover phage therapeutics for infectious diseases. In this collaboration, Sentinel’s novel bacteriophage-based platform will be tested using CarbGeM’s Bacterial Growth Monitor System which enables early detection of bacterial growth by monitoring the optical density (OD) of solid culture plates.
Sentinel Environmental is an environmental biotech company based in Houston, TX, focused on the development of precision microbiome engineering tools for the betterment of human and environmental health. Sentinel’s platform integrates naturally-occurring bacteriophages, metagenomics, and network analysis to achieve sustained and robust microbial control in a cost-effective manner.
By the fusion of biology and digital technology, CarbGeM aims to apply its uniquely developed diagnostic technology to the bacterial infection field. In addition, CarbGeM is trying to solve the global issue of antimicrobial resistance (AMR) through collaborations with world-leading hospitals, universities, and companies.
・Headquarters location: 1-5-13, Jinnan, Shibuya-ku, Tokyo
・CEO: Masakazu Nakajima
・URL： https://carbgem.com/en/
